Lumos Diagnostics (ASX: LDX), known for its rapid point-of-care (POC) diagnostics tests, has expanded its partnership with Henry Schein Medical…
Diagnostic tech company Lumos Diagnostics (ASX: LDX) has received the green card from the US Food and Drug Administration (FDA)…
Rapid antigen tests (or lack thereof) have dominated the headlines for months now. Turning your kitchen counter into a mini…
With ever increasing bodies of medical research and demand for early disease detection climbing, it's high time that we rethink…